Xtant plans to use the proceeds for working capital and other general corporate purposes, according to the report. The sales closed July 6.
Xtant Medical to earn $15M in stock sale
Xtant Medical Holdings, a medical device company focused on surgical solutions for the spine, has agreed to sell 20 million shares of common stock to an investor, resulting in gross proceeds of $15 million, according to a July 3 report from Market Screener.
